Top Medical Stocks To Add to Your Watchlist - May 11th

Hims & Hers Health, UnitedHealth Group, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies involved in the healthcare sector—such as pharmaceutical manufacturers, biotechnology firms, medical device makers and healthcare service providers. Investors buy and sell these equities to gain exposure to advances in drug development, medical technology and patient care trends. As with any equity, medical stocks can fluctuate in value based on regulatory approvals, clinical trial results, reimbursement policies and broader market conditions. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health stock traded up $0.64 during trading hours on Friday, reaching $52.04. The company had a trading volume of 61,754,901 shares, compared to its average volume of 18,348,268. Hims & Hers Health has a 12-month low of $12.07 and a 12-month high of $72.98. The company has a 50-day moving average price of $32.97 and a 200 day moving average price of $32.43. The firm has a market cap of $11.65 billion, a price-to-earnings ratio of 118.28 and a beta of 1.84.

Read Our Latest Research Report on HIMS

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

NYSE:UNH traded down $4.83 during midday trading on Friday, reaching $380.72. 8,371,190 shares of the stock traded hands, compared to its average volume of 4,716,091. The stock has a market capitalization of $346.54 billion, a P/E ratio of 24.56, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group has a 12 month low of $378.54 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a fifty day moving average of $488.01 and a 200 day moving average of $522.31.

Read Our Latest Research Report on UNH

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of NYSE:LLY traded down $15.24 during midday trading on Friday, hitting $736.21. 4,068,043 shares of the stock traded hands, compared to its average volume of 3,517,566. The company has a quick ratio of 0.97, a current ratio of 1.15 and a debt-to-equity ratio of 2.00. The business's 50 day moving average is $810.98 and its two-hundred day moving average is $810.88. The stock has a market capitalization of $697.73 billion, a PE ratio of 62.87, a P/E/G ratio of 1.40 and a beta of 0.48. Eli Lilly and Company has a one year low of $677.09 and a one year high of $972.53.

Read Our Latest Research Report on LLY